The Effect of Cotrimoxazole Prophylactic Treatment on Malaria, Birth Outcomes, and Postpartum CD4 Count in HIV-Infected Women

Figure 1

In the BAN Study, women were enrolled during pregnancy and followed until 48 weeks postpartum. Prior to June 2006, all women received SP-IPTp as recommended by the Malawi Department of Health. Following WHO recommendations, after June 2006 CPT was implemented for women with a CD4 of less than 500 and SP-IPTp was discontinued for these women. Women with a CD4 of 500 or greater continued to receive SP-IPTp.